Pijnenburg YAL - Search Results

1

Social cognition deficits and biometric signatures in the behavioural variant of Alzheimer's disease.

Singleton EH, Fieldhouse JLP, van 't Hooft JJ, Scarioni M, van Engelen ME, Sikkes SAM, de Boer C, Bocancea DI, van den Berg E, Scheltens P, van der Flier WM, Papma JM, Pijnenburg YAL, Ossenkoppele R. Singleton EH, et al. Among authors: pijnenburg yal. Brain. 2023 May 2;146(5):2163-2174. doi: 10.1093/brain/awac382. Brain. 2023. PMID: 36268579 Free PMC article.

2

Generalized synchronization of MEG recordings in Alzheimer's Disease: evidence for involvement of the gamma band.

Stam CJ, van Cappellen van Walsum AM, Pijnenburg YA, Berendse HW, de Munck JC, Scheltens P, van Dijk BW. Stam CJ, et al. J Clin Neurophysiol. 2002 Dec;19(6):562-74. doi: 10.1097/00004691-200212000-00010. J Clin Neurophysiol. 2002. PMID: 12488788 Clinical Trial.

3

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

Pijnenburg YA, Schoonenboom NS, Scheltens P. Pijnenburg YA, et al. Neurology. 2003 Jan 28;60(2):353-4; author reply 353-4. doi: 10.1212/wnl.60.2.353-a. Neurology. 2003. PMID: 12552068 No abstract available.

4

Loss of frontal fMRI activation in early frontotemporal dementia compared to early AD.

Rombouts SA, van Swieten JC, Pijnenburg YA, Goekoop R, Barkhof F, Scheltens P. Rombouts SA, et al. Neurology. 2003 Jun 24;60(12):1904-8. doi: 10.1212/01.wnl.0000069462.11741.ec. Neurology. 2003. PMID: 12821731

5

Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study.

Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, de Jong D, Dooijes D, Kamphorst W, Ravid R, Niermeijer MF, Verheij F, Kremer HP, Scheltens P, van Duijn CM, Heutink P, van Swieten JC. Rosso SM, et al. Brain. 2003 Sep;126(Pt 9):2016-22. doi: 10.1093/brain/awg204. Epub 2003 Jul 22. Brain. 2003. PMID: 12876142

6

Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.

Rosso SM, van Herpen E, Pijnenburg YA, Schoonenboom NS, Scheltens P, Heutink P, van Swieten JC. Rosso SM, et al. Arch Neurol. 2003 Sep;60(9):1209-13. doi: 10.1001/archneur.60.9.1209. Arch Neurol. 2003. PMID: 12975285

7

Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease.

Schoonenboom NS, Pijnenburg YA, Mulder C, Rosso SM, Van Elk EJ, Van Kamp GJ, Van Swieten JC, Scheltens P. Schoonenboom NS, et al. Neurology. 2004 May 11;62(9):1580-4. doi: 10.1212/01.wnl.0000123249.58898.e0. Neurology. 2004. PMID: 15136685

8

CSF tau and Abeta42 are not useful in the diagnosis of frontotemporal lobar degeneration.

Pijnenburg YA, Schoonenboom NS, Rosso SM, Mulder C, Van Kamp GJ, Van Swieten JC, Scheltens P. Pijnenburg YA, et al. Neurology. 2004 May 11;62(9):1649. doi: 10.1212/01.wnl.0000123014.03499.a7. Neurology. 2004. PMID: 15136709 No abstract available.

9

Initial complaints in frontotemporal lobar degeneration.

Pijnenburg YA, Gillissen F, Jonker C, Scheltens P. Pijnenburg YA, et al. Dement Geriatr Cogn Disord. 2004;17(4):302-6. doi: 10.1159/000077159. Dement Geriatr Cogn Disord. 2004. PMID: 15178941

10

Differences and similarities between two frequently used assays for amyloid beta 42 in cerebrospinal fluid.

Schoonenboom NS, Mulder C, Vanderstichele H, Pijnenburg YA, Van Kamp GJ, Scheltens P, Mehta PD, Blankenstein MA. Schoonenboom NS, et al. Clin Chem. 2005 Jun;51(6):1057-60. doi: 10.1373/clinchem.2005.048629. Epub 2005 Apr 21. Clin Chem. 2005. PMID: 15845801 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters